Novartis Ireland Limited

Lobbying Organisation Novartis Ireland Limited

Date published 21 Jan, 2026

Relevant Matter Public policy or programme

Public Policy Area Environment

Period 1 Sep, 2025 to 31 Dec, 2025

Specific Details Meeting with Department of Environment officials about the EU Mercury Committee

Intended results Meeting with officials with regard to Ireland's vote on an EU exemption for development of RLT in the EU. The EU Mercury Committee meeting scheduled in the first week of September

Name of person primarily responsible for lobbying on this activity Eibhlin Mulroe

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

A virtual meeting held on the 4th September to discuss the mercury exemption discussion at EU level and presenting the science around the rationale for exemption in development of Radioligand Therapy. Meeting attended by Novartis colleagues and EPA/DCEE officials.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Darragh O'Brien Minister (Department of Climate, Energy and the Environment)